MedTrace Logo

CXCR4 Targeted PET Imaging in the Diagnosis and Identification of Primary Aldosteronism

NCT06183554 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-01-03

No results posted yet for this study

Summary

This study aimed to prospectively evaluate the utility of C-X-C chemokine receptor type 4 (CXCR4) positron emission tomography (PET) imaging in patients with clinical suspected primary aldosteronism (PA), with postoperative pathological or follow-up results as reference standards.

Conditions

  • Primary Aldosteronism

Interventions

DIAGNOSTIC_TEST

CXCR4

Patients with clinical suspected primary aldosteronism will receive a CXCR4 PET imaging.

Sponsors & Collaborators

  • Xiao Chen

    lead OTHER

Principal Investigators

  • Xiao Chen, Ph.D · Daping Hospital, Army Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06183554 on ClinicalTrials.gov